NEW YORK, Feb 29, 2008 (BUSINESS WIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens and protect the population at large, today announced that its Chief Executive Officer, Dr. Eric Rose, will present an overview of the company's business activities at the upcoming SIGnificant Options in Healthcare Conference in New York. The presentation will take place at 9:00 a.m., March 4th, 2008 in the Arbor Room of the W Hotel at 49th and Lexington.

For one-on-one investor meetings, please contact your SIG representative directly or Lori Aversano at lori.aversano@sig.com.

Interested parties are invited to listen to a live audio webcast of SIGA's investor presentation on Tuesday, March 4, 2008 at 9:00 a.m. Eastern Time at the following link: http://www.wsw.com/webcast/sig7/siga/. An archive of the presentation will be available for replay following the conference.

About SIGA Technologies, Inc.

SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents to fight potential biowarfare pathogens. SIGA has antiviral programs targeting smallpox and other Category A pathogens, including arenaviruses (Lassa fever, Junin, Machupo, Guanarito, Sabia, and lymphocytic choriomeningitis), dengue virus, and the filoviruses (Ebola and Marburg). For more information about SIGA, please visit SIGA's Web site at www.siga.com.

SOURCE: SIGA Technologies, Inc.

INVESTOR 
RELATIONS:
Cameron Associates
Al Palombo, 212-554-5488
al@cameronassoc.com

Copyright Business Wire 2008

News Provided by COMTEX